R. Bruce Aylward - Concepedia

Author

R. Bruce Aylward

Also Known As

R B Aylward, R B. AYLWARD, R Bruce Aylward, R. Aylward, R. B. AYLWARD, R. B. Aylward, R. Bruce Aylward, R.Bruce Aylward, R. Bruce Aylward, R Bruce Aylward

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

World Health Organization Imperial College London Centers for Disease Control and Prevention World Health Organization - Pakistan World Health Organization - India

About

R. Bruce Aylward is an author at World Health Organization specializing in medicine, polio, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.7K
2	Public Health	18	22	1.4K
3	Epidemiology	13	17	1K
4	Engineering	1	1	37
5	Management	1	1	37

R. Bruce Aylward

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
New Strategies for the Elimination of Polio from India Nicholas C. Grassly, Christophe Fraser, Jay D. Wenger, Science VaccinationInfectious Disease ModellingMedicineGlobal HealthEpidemiological Dynamic	2006	275
Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication Radboud J. Duintjer Tebbens, Mark A. Pallansch, Olen M. Kew, Risk Analysis Virus EpidemiologyEpidemiological DynamicEradication Of DiseaseDisease OutbreakInfectious Disease Modelling	2006	172
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study Nicholas C. Grassly, Jay D. Wenger, Sunita Durrani, The Lancet VaccinationVaccine SafetyVaccinologyCell-based Vaccine ProductionProtective Efficacy	2007	158
Economic analysis of the global polio eradication initiative Radboud J. Duintjer Tebbens, Mark A. Pallansch, Stephen L. Cochi, Vaccine Global HealthEconomic AnalysisEconomic EvaluationPublic HealthPolio	2010	146
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial Roland W. Sutter, T. Jacob John, Hemant Jain, The Lancet VaccinationCell-based Vaccine ProductionVaccine SafetyVaccine DevelopmentImmunology	2010	142
Priming after a Fractional Dose of Inactivated Poliovirus Vaccine Sonia Resik, Alina Tejeda, Roland W. Sutter, New England Journal of Medicine	2013	135
Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria Helen E. Jenkins, R. Bruce Aylward, Alex Gasasira, New England Journal of Medicine	2010	133
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial Concepción F. Estívariz, Hamid Jafari, Roland W. Sutter, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyInfectious Disease PreventionVaccine Development	2011	98
The Global Polio Eradication Initiative Dermot Maher, R. Bruce Aylward Tropical Doctor VaccinationGlobal HealthGlobal Health CrisisInternational HealthEradication Of Disease	2001	89
The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses Kimberly M. Thompson, Radboud J. Duintjer Tebbens, Mark A. Pallansch, American Journal of Public Health	2008	81

Page 1